255 related articles for article (PubMed ID: 16943316)
1. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
Liu C; Walker JM
J Neurophysiol; 2006 Dec; 96(6):2984-94. PubMed ID: 16943316
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.
Hohmann AG; Tsou K; Walker JM
J Neurophysiol; 1999 Feb; 81(2):575-83. PubMed ID: 10036261
[TBL] [Abstract][Full Text] [Related]
4. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
[TBL] [Abstract][Full Text] [Related]
6. The cannabinoid receptor agonist, WIN 55,212-2, inhibits cool-specific lamina I medullary dorsal horn neurons.
Ogawa A; Meng ID
Neuroscience; 2006 Nov; 143(1):265-72. PubMed ID: 16949215
[TBL] [Abstract][Full Text] [Related]
7. A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Suplita RL; Hohmann AG
Neuroscience; 2003; 117(3):659-70. PubMed ID: 12617970
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
Nackley AG; Makriyannis A; Hohmann AG
Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
[TBL] [Abstract][Full Text] [Related]
9. Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons.
Papanastassiou AM; Fields HL; Meng ID
Pain; 2004 Feb; 107(3):267-275. PubMed ID: 14736589
[TBL] [Abstract][Full Text] [Related]
10. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.
Herzberg U; Eliav E; Bennett GJ; Kopin IJ
Neurosci Lett; 1997 Jan; 221(2-3):157-60. PubMed ID: 9121688
[TBL] [Abstract][Full Text] [Related]
11. A CB(2) receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: contributions of spinal and peripheral CB(2) receptors.
McGaraughty S; Chu KL; Dart MJ; Yao BB; Meyer MD
Neuroscience; 2009 Feb; 158(4):1652-61. PubMed ID: 19063946
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
Burgos E; Pascual D; Martín MI; Goicoechea C
Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
[TBL] [Abstract][Full Text] [Related]
13. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
14. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
Nackley AG; Zvonok AM; Makriyannis A; Hohmann AG
J Neurophysiol; 2004 Dec; 92(6):3562-74. PubMed ID: 15317842
[TBL] [Abstract][Full Text] [Related]
15. Nociceptive response to innocuous mechanical stimulation is mediated via myelinated afferents and NK-1 receptor activation in a rat model of neuropathic pain.
Pitcher GM; Henry JL
Exp Neurol; 2004 Apr; 186(2):173-97. PubMed ID: 15026255
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors.
Ding Z; Cowan A; Rawls SM
Brain Res; 2005 Dec; 1065(1-2):147-51. PubMed ID: 16309633
[TBL] [Abstract][Full Text] [Related]
18. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K
Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
[TBL] [Abstract][Full Text] [Related]
19. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
Liang YC; Huang CC; Hsu KS
Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.
Hohmann AG; Martin WJ; Tsou K; Walker JM
Life Sci; 1995; 56(23-24):2111-8. PubMed ID: 7776839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
